AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MINOCYCLINE
7 registrations across 3 African markets— 7 active
Markets with MINOCYCLINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MESTACINE comprimé / 100mg | 🇸🇳Senegal | LEDERLE | active | — |
| MESTACINE comprimé / 50mg | 🇸🇳Senegal | LEDERLE | active | — |
| MYNOCINE gélule / 100 mg | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| MYNOCINE® 100MG GELU BTE (1 X 15) LABORATOIRE X.O. gélule, boîte de 1 blister de 15 | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| MINOTREX GELULE | 🇲🇦Morocco | — | active | — |
| MYNOCINE® 100MG GELU BTE (1 X 15) LABORATOIRE X.O. gélule, boîte de 1 blister de 15 | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| MYNOCINE GELULE | 🇲🇦Morocco | — | active | — |
MINOCYCLINE in Africa — Regulatory Overview
MINOCYCLINE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Morocco, Madagascar. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.